MAPT and Alzheimer disease: The fact that we can detect Aβ and tau pathology in a subset of our patient samples, and that these features are retained and can be live-imaged in culture does, however, open exciting future avenues to explore potential sporadic pre-clinical AD pathology in the live adult human brain.